Mesalamine 4 Gm/60 ml/Budesonide 2 mg/60 ml Enema is a specially compounded medication designed to treat a range of inflammatory bowel diseases, including Ulcerative Colitis, Crohn's Disease, Proctitis, Proctosigmoiditis, and Diverticulitis. This unique formulation combines the anti-inflammatory properties of mesalamine with the corticosteroid budesonide, creating a potent combination that effectively reduces inflammation and alleviates the symptoms associated with these conditions.

The medication is contained in a ready-to-use liquid formulation within pre-filled enema bottles. This method of delivery allows for direct application of the medication to the affected area, providing rapid symptom relief. The pre-filled enema bottles offer a measured dose of the solution, ensuring easy and controlled application without the need for additional preparation, making it a convenient and hygienic method for targeted treatment.

This formulation can be used as a standalone treatment or in conjunction with other medications to provide a comprehensive approach to managing these diseases. However, patients should be aware that this medication may cause side effects such as nausea, vomiting, and abdominal pain. It is also important to note that this medication may interact with other drugs, so it is crucial to consult with a healthcare provider before starting this treatment.

Healthcare providers should be aware that this is a compounded medication, which may have potential for drug interactions and side effects. It is also important to consider the potential for drug incompatibilities. Consulting with a compounding pharmacist can ensure the safety and efficacy of this formulation.

If you have any questions about this formulation or its use in treating these diseases, please do not hesitate to contact us at Bayview Pharmacy. Our team of compounding pharmacists is ready to assist you with any queries you may have.

This compounded formulation of Mesalamine 4 Gm/60 ml/Budesonide 2 mg/60 ml Enema is a ready-to-use liquid solution, specifically designed for rectal administration. It is contained in pre-filled enema bottles, providing a convenient and hygienic method for targeted treatment of various gastrointestinal conditions such as Ulcerative Colitis, Crohn's Disease, Proctitis, Proctosigmoiditis, and Diverticulitis.

Mesalamine, an anti-inflammatory agent, works by reducing inflammation in the lining of the intestines. Budesonide, a corticosteroid, aids in reducing inflammation and suppressing the immune system. The combination of these two medications can help alleviate symptoms associated with these diseases, including abdominal pain, diarrhea, and rectal bleeding.

It is crucial to understand that this formulation is not intended for treating acute flare-ups of these diseases. It is designed for maintenance therapy and may take several weeks to start working, with full effects potentially visible after several months. Therefore, patience and consistent use are key to achieving the desired therapeutic outcomes.

Patients should also be aware of potential side effects, which may include nausea, vomiting, headache, and dizziness. If any of these side effects occur, it is recommended to contact a healthcare provider immediately. This formulation is a significant advancement in the treatment of these disease states, offering a measured dose of the solution for easy and controlled application without the need for additional preparation.

Mesalamine 4 Gm/60 ml/Budesonide 2 mg/60 ml Enema is a compounded formulation designed to treat a range of inflammatory bowel diseases such as Ulcerative Colitis, Crohn's Disease, Proctitis, Proctosigmoiditis, and Diverticulitis. This formulation combines two potent medications, Mesalamine and Budesonide, both of which work synergistically to reduce inflammation in the intestines. Mesalamine is an anti-inflammatory drug that targets inflammation in the intestinal lining, while Budesonide, a corticosteroid, reduces inflammation and suppresses the immune system. Together, these medications help alleviate the symptoms associated with these diseases.

The administration of this medication is rectal, typically once or twice daily as per the healthcare provider's instructions. The patient is advised to lie on their left side, with their knees bent and head slightly elevated. The enema is then inserted into the rectum, and the solution is slowly released. It is recommended that the patient remains in this position for at least 15 minutes to ensure optimal absorption of the medication. Following the administration, the patient should continue to lie down for a minimum of 30 minutes before getting up.

Adherence to the prescribed dosage and duration of treatment is crucial for the effectiveness of this medication. It is not advisable to use more or less of the medication than prescribed, or to use it for a longer period than recommended by your healthcare provider. If you have any queries or concerns about the use of this medication, it is important to consult with your healthcare provider or pharmacist.

This compounded formulation of Mesalamine 4 Gm/60 ml/Budesonide 2 mg/60 ml Enema is a ready-to-use liquid solution, conveniently contained in pre-filled enema bottles for rectal administration. It is primarily designed for the targeted treatment of various gastrointestinal conditions such as Ulcerative Colitis, Crohn's Disease, Proctitis, Proctosigmoiditis, and Diverticulitis. It may also be beneficial in managing other conditions like radiation proctitis, pouchitis, and microscopic colitis.

It is crucial to understand that this formulation should only be used for the conditions mentioned above, unless otherwise directed by a healthcare provider. It is not suitable for patients with a known hypersensitivity to either mesalamine or budesonide. The pre-filled enema bottles provide a measured dose of the solution, ensuring easy and controlled application without the need for additional preparation. This offers a hygienic and convenient method for medication delivery.

Always consult with a healthcare provider before starting any new medication or treatment. If you have any questions or concerns about this formulation, it is recommended to seek professional medical advice.